23andMe gets thumbs up from big pharma with $50 million Genentech deal

January 6, 2015 9:31 PM

2 0

The FDA might have banned its home testing kits in the US, but 23andMe still has a stockpile of genetic data to sell to medical giants

Despite setbacks from regulators, 23andMe is attracting serious interest from heavy-hitters in the pharmaceutical industry. The ambitious genetics startup has received a first payment of $10 million from biotech company Genentech in exchange for genetic data donated by customers of 23andMe’s persona...

Read more

To category page